Preferred Label : afamelanotide;
MeSH note : observations suggest that afamelanotide has beneficial effects in patients with erythropoietic
protoporphyria, induces epidermal melanin formation;
CISMeF synonym : CUV1647; Scenesse;
MeSH hyponym : CUV-1647;
MeSH Related Number : 1XCC161YKC;
Is substance : O;
UNII : QW68W3J66U;
Origin ID : C534526;
UMLS CUI : C2607750;
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3192396/fr/scenesse
2020
false
false
false
France
afamelanotide
afamelanotide
insurance, health, reimbursement
treatment outcome
drug implants
dermatologic agents
protoporphyria, erythropoietic
phototoxicity
adult
Product containing only afamelanotide in subcutaneous dose form (medicinal product
form)
rare diseases
evaluation of the transparency committee
dermatitis, phototoxic
alpha-msh
alpha-msh
---
https://www.ema.europa.eu/medicines/human/EPAR/Scenesse
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
afamelanotide
afamelanotide
afamelanotide
orphan drug production
rare diseases
drug approval
europe
protoporphyria, erythropoietic
alpha-msh
drug implants
injections, subcutaneous
risk management
drug monitoring
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
adult
drug evaluation, preclinical
phototoxicity
dermatitis, phototoxic
---